Patrick Radden Keefe, The New Yorker
The Trump Administration is poised to make a settlement with Purdue Pharma that it can claim as a victory for opioid victims. But the proposed outcome would leave the company’s owners enormously wealthyand off the hook for good.

RealClearInvestigations – Homepage